Sergio Islas‐Andrade

2.2k total citations
51 papers, 636 citations indexed

About

Sergio Islas‐Andrade is a scholar working on Endocrinology, Diabetes and Metabolism, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Sergio Islas‐Andrade has authored 51 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Public Health, Environmental and Occupational Health and 9 papers in Molecular Biology. Recurrent topics in Sergio Islas‐Andrade's work include Adipokines, Inflammation, and Metabolic Diseases (6 papers), Ethics and bioethics in healthcare (5 papers) and Pharmaceutical Practices and Patient Outcomes (4 papers). Sergio Islas‐Andrade is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (6 papers), Ethics and bioethics in healthcare (5 papers) and Pharmaceutical Practices and Patient Outcomes (4 papers). Sergio Islas‐Andrade collaborates with scholars based in Mexico, Argentina and Germany. Sergio Islas‐Andrade's co-authors include M. Revilla, Adolfo Andrade‐Cetto, Cristina Fernández‐Mejía, Armida Báez‐Saldaña, Martha Rodrı́guez-Morán, Helmut Wiedenfeld, Esperanza Martı́nez-Abundis, Jorge Escobedo, Silvia Esperanza Flores‐Martínez and Fernando Guerrero‐Romero and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Clinical Nutrition.

In The Last Decade

Sergio Islas‐Andrade

45 papers receiving 609 citations

Peers

Sergio Islas‐Andrade
Asadollah Rajab Iran
Mesbah Shams Iran
Shridhar Dwivedi India
Ipseeta Ray Mohanty India
Qiu Zhang China
Lorena Ciumărnean Romania
Vasile Negrean Romania
Jasvinder K. Gambhir India
Dunya Tomic Australia
Mehrnoosh Zakerkish Iran
Asadollah Rajab Iran
Sergio Islas‐Andrade
Citations per year, relative to Sergio Islas‐Andrade Sergio Islas‐Andrade (= 1×) peers Asadollah Rajab

Countries citing papers authored by Sergio Islas‐Andrade

Since Specialization
Citations

This map shows the geographic impact of Sergio Islas‐Andrade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio Islas‐Andrade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio Islas‐Andrade more than expected).

Fields of papers citing papers by Sergio Islas‐Andrade

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergio Islas‐Andrade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio Islas‐Andrade. The network helps show where Sergio Islas‐Andrade may publish in the future.

Co-authorship network of co-authors of Sergio Islas‐Andrade

This figure shows the co-authorship network connecting the top 25 collaborators of Sergio Islas‐Andrade. A scholar is included among the top collaborators of Sergio Islas‐Andrade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergio Islas‐Andrade. Sergio Islas‐Andrade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Islas‐Andrade, Sergio, Óscar Arrieta, Miguel Á. Celis, et al.. (2023). Cannabinoids and their therapeutic use. Gaceta Médica de México. 159(1). 1–2. 1 indexed citations
2.
Islas‐Andrade, Sergio, Óscar Arrieta, Judith Domínguez‐Cherit, et al.. (2023). Cannabinoides y su uso terapéutico. SHILAP Revista de lepidopterología. 159(1).
3.
Lifshitz, Alberto, Óscar Arrieta, Miguel Á. Celis, et al.. (2021). Importance of the list of essential medicines in medical prescription. Gaceta Médica de México. 156(6). 598–599. 2 indexed citations
4.
Arrieta, Óscar, Miguel Á. Celis, Sergio Islas‐Andrade, et al.. (2021). Medical prescription: conditioned reflex or conscious reflection?. Gaceta Médica de México. 156(6). 603–605. 1 indexed citations
5.
Mendoza‐Caamal, Elvia, Francisco Barajas‐Olmos, Carlos A. Aguilar‐Salinas, et al.. (2021). Two novel variants in DYRK1B causative of AOMS3: expanding the clinical spectrum. Orphanet Journal of Rare Diseases. 16(1). 291–291. 7 indexed citations
6.
Méndez-García, Lucía Angélica, et al.. (2021). Cord blood levels of interleukin-10 decrease in neonates with increased birth weight: novel implications of the cytokine network in early obesity. European Journal of Pediatrics. 180(8). 2529–2537. 3 indexed citations
7.
Méndez-García, Lucía Angélica, et al.. (2020). Low Serum Interleukin-6 Is a Differential Marker of Obesity-Related Metabolic Dysfunction in Women and Men. Journal of Interferon & Cytokine Research. 40(3). 131–138. 9 indexed citations
8.
Palomera, L., Raúl Alcántara-Suárez, Lucía Angélica Méndez-García, et al.. (2019). A Single 48 mg Sucralose Sip Unbalances Monocyte Subpopulations and Stimulates Insulin Secretion in Healthy Young Adults. Journal of Immunology Research. 2019. 1–10. 8 indexed citations
9.
León‐Cabrera, Sonia, Felix Rückert, José Manuel Fragoso, et al.. (2018). High-Density Lipoprotein Reduction Differentially Modulates to Classical and Nonclassical Monocyte Subpopulations in Metabolic Syndrome Patients and in LPS-Stimulated Primary Human Monocytes In Vitro. Journal of Immunology Research. 2018. 1–12. 13 indexed citations
10.
Verástegui, Emma, Ricardo Plancarte, Óscar Arrieta, et al.. (2018). Recomendaciones para la prescripción segura de opioides en el manejo del dolor crónico no oncológico. Gaceta Médica de México. 154(4). 532–533. 1 indexed citations
11.
Celis, Miguel Á., Óscar Arrieta, Sergio Islas‐Andrade, et al.. (2018). El consentimiento informado: recomendaciones para su documentación. Gaceta Médica de México. 154(6). 716–718. 2 indexed citations
12.
Sánchez-López, Antonio Manuel, et al.. (2016). Clinical testing of propofol geriatic dose for sedation designed via in silico trial. Computer Methods and Programs in Biomedicine. 132. 21–27. 4 indexed citations
13.
Fernández, I. González, Guadalupe Domínguez-Gómez, Luis Felipe Jiménez‐García, et al.. (2015). Drug Development in Conformational Diseases: A Novel Family of Chemical Chaperones that Bind and Stabilise Several Polymorphic Amyloid Structures. PLoS ONE. 10(9). e0135292–e0135292. 17 indexed citations
14.
Altamirano-Bustamante, Nelly, et al.. (2014). Novel ethical dilemmas arising in geriatric clinical practice. Medicine Health Care and Philosophy. 18(2). 229–236. 3 indexed citations
15.
González-Ortı́z, Manuel, Niels H. Wacher, Esperanza Martı́nez-Abundis, et al.. (2008). Efficacy of glimepiride/metformin combination versus glibenclamide/metformin in patients with uncontrolled type 2 diabetes mellitus. Journal of Diabetes and its Complications. 23(6). 376–379. 37 indexed citations
16.
Guerrero‐Romero, Fernando, Martha Rodrı́guez-Morán, Ricardo Pérez-Fuentes, et al.. (2008). Prediabetes and its Relationship with Obesity in Mexican Adults: The Mexican Diabetes Prevention (MexDiab) Study. Metabolic Syndrome and Related Disorders. 6(1). 15–23. 47 indexed citations
17.
Revilla, M., et al.. (2006). Biotin supplementation reduces plasma triacylglycerol and VLDL in type 2 diabetic patients and in nondiabetic subjects with hypertriglyceridemia. Biomedicine & Pharmacotherapy. 60(4). 182–185. 37 indexed citations
18.
19.
Pérez, Carlos Enrique Tene, M. Revilla, Dante Amato, et al.. (2004). Correlation Between Serum Leptin Levels and Insulin Sensitivity in Diffuse Toxic Goiter. Endocrine Research. 30(1). 19–27. 5 indexed citations
20.
Flores‐Martínez, Silvia Esperanza, et al.. (2004). DNA polymorphism analysis of candidate genes for type 2 diabetes mellitus in a Mexican ethnic group. Annales de Génétique. 47(4). 339–348. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Asadollah Rajab Breakdown of academic impact, for papers by Mesbah Shams Breakdown of academic impact, for papers by Shridhar Dwivedi Breakdown of academic impact, for papers by Ipseeta Ray Mohanty Breakdown of academic impact, for papers by Qiu Zhang Breakdown of academic impact, for papers by Lorena Ciumărnean Breakdown of academic impact, for papers by Vasile Negrean Breakdown of academic impact, for papers by Jasvinder K. Gambhir Breakdown of academic impact, for papers by Dunya Tomic Breakdown of academic impact, for papers by Mehrnoosh Zakerkish
Rankless by CCL
2026